IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
$14.22
-0.07% today · +29.27% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- IOVA −0.07% on the last session vs SPY +0.74%: −0.8 pts of stock-specific move.
- Aftermath, big gain (Sep 29): After its 63 big gains in the past 5 years, IOVA typically gained 1.0% over the next day (median) and was higher 56% of the time; half the outcomes fell between -2.9% and +3.5%. An ordinary day: -0.3%. Among S&P 500 stocks after big gains, that ranks #168 of 500.
- 1 Reddit mentions in the past 24 hours, 82% positive over the week.
- 2 analyst actions in the past 10 days (2 positive, 0 negative); latest: Wells Fargo maintained Overweight, raised target $14.00 → $18.00.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
IOVA against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #307 | -0.07% | +0.74% | |
| 1 week | #1 | +29.27% | -0.22% | |
| 1 month | #1 | +64.97% | +0.84% | |
| 3 months | #1 | +229.93% | +3.59% | |
| 6 months | #1 | +314.58% | +17.95% | |
| 1 year | #4 | +532.00% | +16.25% | |
| Overall | #17 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Biotechnology
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | -0.04 | #473 | #5 |
| fPE/tPE | #1 | #1 | |
| PE/G | #1 | #1 | |
| EV/Revenue | 19.04 | #16 | #2 |
| Gross Margin | 0.48 | #223 | #4 |
| Profit Margin | -0.89 | #476 | #5 |
| Revenue Growth | 0.66 | #15 | #1 |